MOTS-c dosage chart: no human dosage is approved. Learn what animal studies show, why dosing varies, and safety facts for this investigational peptide.
There is no official MOTS-c dosage chart for humans. MOTS-c is an investigational mitochondrial peptide that is not FDA-approved for any medical condition. Any dosage numbers you see online come from animal studies or vendor suggestions, not from controlled human trials.
What Is MOTS-c and Why People Search for a Dosage Chart
MOTS-c is a 16-amino acid peptide encoded within mitochondrial DNA. Researchers study it for its role in metabolic regulation, insulin sensitivity, and exercise response. Because it is sold online as a research chemical, many people search for a mots c dosage chart hoping to find safe human dosing.
That search often leads to confusing results. Some sites show a mots-c peptide dosage chart with specific micrograms or milligrams, but those numbers are not based on human clinical trials. No regulatory agency has approved MOTS-c for human use.
Why No Standard Human MOTS-c Dosage Exists
MOTS-c is not FDA-approved for human use in the United States. It has not completed the clinical trial process required to establish safety, efficacy, or dosing. Most human data on MOTS-c comes from observational studies measuring natural levels in the blood, not from giving the peptide as a drug.
Without phase 1 and phase 2 trials, there is no way to know a safe starting dose, a maximum tolerated dose, or how often to administer it. A reliable dosage chart requires that information. This is why any human MOTS-c dosage you see is speculative.
Other peptides face similar problems. If you have seen a bpc-157 dosage chart by weight, you know that even popular research peptides lack standardized human dosing. BPC-157 is also not FDA-approved for human use.
Natural MOTS-c levels also vary widely based on age, exercise habits, and metabolic health. Measuring these levels does not tell you what dose to inject. A blood test is not a dosage chart.
What Animal Research Shows About MOTS-c Dosing
Preclinical studies in mice and other animals have used a range of MOTS-c doses. These studies help scientists understand the peptide's biology, but they do not provide a human dosage chart. Researchers often describe a mots-c peptide dosage protocol in milligrams per kilogram of body weight, given by injection.
Below is a summary of doses reported in published animal research. These are not recommendations for human use.
| Reported Dose | Route | Frequency | Animal Model | Observed Effects |
|---|---|---|---|---|
| 0.5 mg/kg | Intraperitoneal | Daily | Mice on high-fat diet | Improved insulin sensitivity |
| 5 mg/kg | Intraperitoneal | Daily or every other day | Obese mice | Reduced weight gain, better glucose tolerance |
| 15 mg/kg | Intraperitoneal | Three times per week | Aged mice | Improved physical performance |
Animal doses cannot be converted directly to human doses. Species differences in metabolism, half-life, and receptor sensitivity make such calculations unreliable. The only honest answer to "what is the MOTS-c dosage for humans?" is that no one knows.
How to Evaluate a Vendor's MOTS-c Dosage Chart
Many online vendors sell MOTS-c as a research chemical and provide a suggested dosage chart. These charts typically list amounts like 5 mg to 10 mg per week, sometimes split into several injections. None of these numbers come from human clinical trials.
When you see a lipo-c peptide dosage chart or a pt-141 peptide dosage chart, you are looking at similar vendor-created information. Some of these peptides have more human data than others, but MOTS-c has almost none. A vendor chart is not a substitute for medical evidence.
Be wary of any site that claims a specific MOTS-c dosage will produce fat loss, better exercise performance, or anti-aging effects. Those claims are not proven in humans. Selling peptides for human use without FDA approval is illegal, even if the product is labeled "for research only."
Safety and Legal Status of MOTS-c
MOTS-c is not approved by the FDA for any human use. Injecting an unapproved peptide carries risks, including allergic reactions, injection site infections, and unknown long-term effects. Because clinical trials have not been done, we do not know the side effect profile.
If you are considering MOTS-c for any health reason, talk to a licensed healthcare professional. They can help you understand approved treatment options for conditions like insulin resistance or obesity. Do not use research peptides as a substitute for medical care.
Some researchers are studying MOTS-c analogs for metabolic diseases, but those studies are in early stages. Even if future trials succeed, the resulting dosage chart will come from controlled human data, not from online vendor pages.
Key Takeaways on MOTS-c Dosing
- MOTS-c is not FDA-approved for human use in the United States.
- No human trials have established a safe or effective MOTS-c dosage.
- Animal research doses range from 0.5 mg/kg to 15 mg/kg but do not translate directly to humans.
- Vendor-supplied dosage charts are not medical evidence.
- Consult a healthcare professional before using any unapproved peptide.
Frequently Asked Questions
Is there a MOTS-c dosage chart for humans?
No. MOTS-c is not FDA-approved for human use, and no clinical trials have established a safe or effective dosage. Any human dosage chart you see online is based on animal data or vendor claims, not medical evidence.
What is the typical MOTS-c dosage used in research?
Animal studies have used doses ranging from 0.5 mg/kg to 15 mg/kg, usually given by intraperitoneal injection. These doses are not directly translatable to humans, and no human research has confirmed a typical dosage.
Is MOTS-c legal to buy in the US?
MOTS-c can be sold as a research chemical for laboratory use, but it is not legal to sell for human consumption. Purchasing it for personal injection is not FDA-approved, and the product may be of unknown purity or quality.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.